Skip to main content
Home
FULL MENU Close Menu
Home
Home

Susan London

News

Pembrolizumab bests chemo in PD-L1-positive esophageal cancer

Author:
Susan London
Publish date: January 23, 2019

SAN FRANCISCO – In KEYNOTE-181, second-line pembrolizumab reduced risk of death by 31% relative to chemotherapy among patients whose esophageal...

  • Read More

News

Age may dictate benefit of andecaliximab in gastric cancer

Author:
Susan London
Publish date: January 22, 2019

SAN FRANCISCO – Older adults appeared to derive both progression-free and overall survival benefit in the GAMMA-1 trial, which tested addition of...

  • Read More

News

COLOPEC: Adjuvant HIPEC for high-risk colon cancer disappoints

Author:
Susan London
Publish date: January 22, 2019

SAN FRANCISCO – Adding adjuvant oxaliplatin HIPEC to routine adjuvant systemic chemotherapy did not improve survival without peritoneal recurrence...

  • Read More

News

Young women opt for mastectomy even when neoadjuvant chemo works well

Author:
Susan London
Publish date: December 28, 2018

SAN ANTONIO – Although neoadjuvant chemotherapy doubled the proportion of women eligible for breast-conserving surgery, about 40% chose mastectomy...

  • Read More

News

Older breast cancer patients given adjuvant chemo live longer

Author:
Susan London
Publish date: December 27, 2018

SAN ANTONIO – Overall survival is better in breast cancer patients aged 65 years and older who receive adjuvant chemotherapy, although patients...

  • Read More

News

QOL is poorer for young women after mastectomy than BCS

Author:
Susan London
Publish date: December 18, 2018

SAN ANTONIO – A cohort study of 560 breast cancer survivors aged 40 or younger at diagnosis finds that breast satisfaction and several domains of...

  • Read More

News

Oxybutynin rapidly quells hot flashes

Author:
Susan London
Publish date: December 14, 2018

SAN ANTONIO - Oxybutynin reduced hot flash scores by at least two-thirds, improved measures of quality of life, and was safe and well tolerated in...

  • Read More

News

Partial- and whole-breast irradiation very close in efficacy

Author:
Susan London
Publish date: December 12, 2018

SAN ANTONIO – A phase 3 trial among women who had undergone lumpectomy could not refute the hypothesis that PBI was inferior to WBI, but the...

  • Read More

News

AMAROS: Radiation has edge for axillary treatment

Author:
Susan London
Publish date: December 11, 2018

SAN ANTONIO – In patients with a positive sentinel node, axillary radiation has similar efficacy to axillary lymph node dissection and less...

  • Read More

Video

Oxybutynin nets dramatic reduction in hot flashes

Author:
Susan London
Publish date: December 7, 2018

SAN ANTONIO – The 6-week reduction in a hot flash score capturing both frequency and severity was about 30% with placebo, 65% with oxybutynin 2.5...

  • Read More

Video

Extent of breast surgery is tied to quality of life among young breast cancer survivors

Author:
Susan London
Publish date: December 7, 2018

SAN ANTONIO – Younger breast cancer patients who undergo unilateral or bilateral mastectomy report lower breast satisfaction and poorer...

  • Read More

News

pCR may obviate need for adjuvant chemotherapy

Author:
Susan London
Publish date: December 7, 2018

SAN ANTONIO – A meta-analysis finds no added event-free survival benefit from adjuvant chemotherapy among the 21.1% of patients who achieved a pCR...

  • Read More

Video

RT of lymph nodes as good as dissection for the long-term

Author:
Susan London
Publish date: December 6, 2018

SAN ANTONIO – Both axillary RT and axillary lymph node dissection provide excellent, comparable locoregional control in patients with early-stage...

  • Read More

Video

Nothing to gain from chemo after pCR achieved

Author:
Susan London
Publish date: December 6, 2018

SAN ANTONIO - The only thing women with localized breast cancer who achieve a pCR after neoadjuvant chemo may gain from further chemo from...

  • Read More

Video

Small absolute difference between partial and whole breast irradiation

Author:
Susan London
Publish date: December 6, 2018

SAN ANTONIO – A phase 3 trial was unable to rule out the possibility that, after lumpectomy, partial breast irradiation is inferior to whole...

  • Read More

Pages

  • « first
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • …
  • last »

Privacy Policy

Terms of Use

Editorial Policy

Cookie Policy

Ad Policy

Medscape Customer Support

Frequently Asked Questions

 

Advertise with MDedge

See more with MDedge! See our Other Publications

MDedge: Keeping You Informed. Saving You Time.

Copyright  © 2022 Frontline Medical Communications Inc., Newark, NJ, USA. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

Close